Allogene Therapeutics News - ALLO

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Allogene Therapeutics Inc ALLO NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.84 4.03% 21.69 21.18 22.12 21.26 20.85 12:06:16
more quote information »

Recent News

Date Time Source Heading
4/01/202008:30GLOBEAllogene Therapeutics Announces Participation in Two..
3/27/202008:18EDGARCurrent Report Filing (8-k)
3/24/202007:00PRNUSMaxCyte and Allogene Therapeutics Sign Clinical and..
3/20/202016:39EDGARStatement of Changes in Beneficial Ownership (4)
3/20/202016:38EDGARStatement of Changes in Beneficial Ownership (4)
3/20/202016:38EDGARStatement of Changes in Beneficial Ownership (4)
3/20/202016:38EDGARStatement of Changes in Beneficial Ownership (4)
3/20/202016:37EDGARStatement of Changes in Beneficial Ownership (4)
3/18/202016:33EDGARStatement of Changes in Beneficial Ownership (4)
3/18/202016:33EDGARStatement of Changes in Beneficial Ownership (4)
3/18/202016:32EDGARStatement of Changes in Beneficial Ownership (4)
3/11/202016:40EDGARStatement of Changes in Beneficial Ownership (4)
3/11/202016:39EDGARStatement of Changes in Beneficial Ownership (4)
2/27/202017:02EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/27/202016:14EDGARAnnual Report (10-k)
2/27/202007:31EDGARCurrent Report Filing (8-k)
2/27/202004:30GLOBEAllogene Therapeutics Reports Fourth Quarter and Full Year..
2/24/202017:15EDGARStatement of Changes in Beneficial Ownership (4)
2/19/202008:30GLOBEAllogene Therapeutics to Report Fourth Quarter and Full Year..
2/14/202012:05EDGARStatement of Ownership (sc 13g)
2/13/202016:09EDGARAmended Statement of Ownership (sc 13g/a)
2/13/202016:08EDGARAmended Statement of Ownership (sc 13g/a)
2/06/202008:30GLOBEAllogene Therapeutics Announces February and March 2020..
1/13/202006:00GLOBEAllogene Therapeutics and SpringWorks Therapeutics Announce..
1/02/202008:30GLOBEAllogene Therapeutics to Present at the 38th Annual J.P...
11/11/201908:30GLOBEAllogene Therapeutics Announces Year-End 2019 Media Event..
11/06/201909:02GLOBEAllogene Therapeutics Announces Pre-Clinical Data..
11/05/201916:41EDGARCurrent Report Filing (8-k)
11/05/201916:32EDGARAutomatic Shelf Registration Statement of Securities of..
11/05/201916:03EDGARQuarterly Report (10-q)
11/05/201907:33EDGARCurrent Report Filing (8-k)
11/05/201907:30GLOBEAllogene Therapeutics Reports Third Quarter 2019 Financial..
11/05/201906:28GLOBEAllogene Therapeutics and Notch Therapeutics Announce..
10/29/201908:30GLOBEAllogene Therapeutics to Report Third Quarter 2019 Financial..
9/25/201918:28EDGARStatement of Changes in Beneficial Ownership (4)
9/25/201918:25EDGARStatement of Changes in Beneficial Ownership (4)
9/19/201908:00GLOBEAllogene Therapeutics Enters Research Collaboration Directed..
9/18/201919:06EDGARStatement of Changes in Beneficial Ownership (4)
9/09/201918:04EDGARStatement of Changes in Beneficial Ownership (4)
9/09/201918:02EDGARStatement of Changes in Beneficial Ownership (4)
9/05/201916:44EDGARStatement of Changes in Beneficial Ownership (4)
9/05/201916:42EDGARInitial Statement of Beneficial Ownership (3)
9/03/201908:30GLOBEAllogene Therapeutics Announces September 2019 Investor..
8/07/201916:23EDGARQuarterly Report (10-q)
8/07/201907:39EDGARCurrent Report Filing (8-k)
8/07/201907:30GLOBEAllogene Therapeutics Reports Second Quarter 2019 Financial..
8/05/201906:00GLOBEAllogene Therapeutics Appoints Rafael G. Amado, M.D. as ..
7/30/201918:24EDGARStatement of Changes in Beneficial Ownership (4)
7/29/201908:30GLOBEAllogene Therapeutics to Report Second Quarter 2019..
7/22/201916:27EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NASDAQ
ALLO
Allogene T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.